Recipharm acquires Portuguese CDMO as part of biologics expansionnews2022-02-01T13:37:11+00:00February 1st, 2022|Fierce Pharma|
West and Corning team up for injectable drug delivery projectnews2022-02-01T11:46:13+00:00February 1st, 2022|Fierce Pharma|
Stevanato doubles down on pen injector technology, expanding into indications beyond diabetesnews2022-02-01T11:42:13+00:00February 1st, 2022|Fierce Pharma|
VCs infuse $215M into Sanofi-backed wearable subcutaneous drug delivery player Enable Injectionsnews2022-02-01T11:39:08+00:00February 1st, 2022|Fierce Pharma|
CMS’ Biogen decision could spell problems for Lilly, Roche Alzheimer’s drugs, half of surveyed neurologists saynews2022-02-01T09:55:33+00:00February 1st, 2022|Fierce Pharma|
Teva survey finds COVID has ‘widened the chasm’ on health disparitiesnews2022-02-01T01:27:51+00:00February 1st, 2022|Fierce Pharma|
Novavax finally submits its COVID-19 vaccine to the FDA. Is it too late?news2022-01-31T20:28:31+00:00January 31st, 2022|Fierce Pharma|
AbbVie’s new migraine meds could each pull in $2B at peak thanks to class growth, analyst saysnews2022-01-31T18:24:24+00:00January 31st, 2022|Fierce Pharma|
FDA commissioner nominee Califf makes ethics pledge to Sen. Warren in bid for her support: reportnews2022-01-31T17:54:01+00:00January 31st, 2022|Fierce Pharma|
FDA commissioner nominee Califf makes ethics pledge to Warren in bid for her support: reportnews2022-01-31T17:54:01+00:00January 31st, 2022|Fierce Pharma|
